Analysts say Roches potential is underestimated

Most of the analysts mean the stock is cheap at this level. Currently the company is being followed by 18 analysts. The recommendations for the stock contain no sells, 2 times hold and 16 times buy. The average of the outstanding target prices for the stock is at 287,06 CHF. This is approximately 15 percent more than the current price of 246,9 CHF. The latest 3 recommendations for the pharmaceutical company were provided by Berenberg, Barclays and Jefferies & Co..

Target prices for Roche quite concentrated

Based on the current number of outstanding shares Roche 's market capitalization is 170,86 billion CHF.

Price data Roche 2007-2017

At 9.35 the stock trades 0,65 percent lower at 246,9 CHF.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.